$CYTR CYTRX CORP Insider Trading
Get free email notifications about insider trading in CYTRX CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CYTRX CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in CYTRX CORP for free.
IRS Number: 581642750
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CYTR
Company Address: 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES 90049
Phone number: 310-826-5648
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.
Market Capitalization: $38.92M
Prev close: $0.42
Average Daily Volume: 1,450,350
Days Low: $0.40
Year Low: $0.36
Year High: $3.66
CYTRX CORP Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20 2020 | CYTR | CYTRX CORP | Brien Earl W | Director | Option Exercise | M | 0.26 | 150,000 | 39,000 | 300,000 | |
| Aug 20 2020 | CYTR | CYTRX CORP | Brien Earl W | Director | Buy | M | 0.26 | 150,000 | 39,000 | 590,247 | 440.2 K to 590.2 K (+34.07 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Option Exercise | M | 0.26 | 3,000,000 | 780,000 | 0 | |
| Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Payment of Exercise | F | 0.67 | 1,164,179 | 780,000 | 3,668,038 | 4.8 M to 3.7 M (-24.09 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | Chief Executive Off ... | Buy | M | 0.26 | 3,000,000 | 780,000 | 4,832,217 | 1.8 M to 4.8 M (+163.74 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | M | 0.26 | 700,000 | 182,000 | 0 | |
| Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Payment of Exercise | F | 0.67 | 271,642 | 182,000 | 600,785 | 872.4 K to 600.8 K (-31.14 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Buy | M | 0.26 | 700,000 | 182,000 | 872,427 | 172.4 K to 872.4 K (+405.97 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | M | 0.26 | 450,000 | 117,000 | 0 | |
| Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Payment of Exercise | F | 0.67 | 174,627 | 117,000 | 335,373 | 510 K to 335.4 K (-34.24 %) |
| Aug 13 2020 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Buy | M | 0.26 | 450,000 | 117,000 | 510,000 | 60 K to 510 K (+750.00 %) |
| Dec 17 2019 | CYTR | CYTRX CORP | KRIEGSMAN STEVEN A | CEO | Option Exercise | A | 0.26 | 3,000,000 | 780,000 | 3,000,000 | |
| Dec 17 2019 | CYTR | CYTRX CORP | IGNARRO LOUIS | Director | Option Exercise | A | 0.26 | 700,000 | 182,000 | 700,000 | |
| Dec 17 2019 | CYTR | CYTRX CORP | CALOZ JOHN Y | Chief Financial Off ... | Option Exercise | A | 0.26 | 350,000 | 91,000 | 350,000 | |
| Dec 17 2019 | CYTR | CYTRX CORP | Caldwell Joel K | Director | Option Exercise | A | 0.26 | 450,000 | 117,000 | 450,000 |